Amid continued conversations about legalizing cannabis in Pennsylvania comes new research suggesting a potential brain pathway involved in cannabis use disorder and psychosis.

It’s one of the first studies to suggest a specific brain pathway for cannabis use disorder, or problematic use of cannabis that impairs daily life, which has been increasing in the past couple of decades as the drug becomes more widely available and the concentration of tetrahydocannabidiol (THC), the plant’s psychoactive component, increases.

Published in JAMA Psychiatry last month, the study imaged the brains of people with and without cannabis use disorder (CUD), some being treated for psychosis. Researchers found that those with CUD had stronger signals in portions of the substantia nigra, a brain region important for dopamine release and previously linked to psychosis symptoms.

The results of the research, led by scientists at McGill University in Canada, do not mean cannabis causes all people to experience psychosis, but point to a potential mechanism for why cannabis may induce psychosis in some people.

Advertise with us

“This study may instill fear in some people,” said Jessica Ahrens, a PhD candidate at McGill interested in schizophrenia and lead author on the paper. “And that’s really not my goal. I think if people are really struggling with their cannabis use, if they just reduce it, it might be helpful.”

Area physicians have seen an increase in both cannabis use disorder and cannabis-induced psychosis. (Associated Press)

One 2015 study that looked at cannabis use disorder in 2001 and 2013 found the incidence of the condition more than doubled over that timespan. More recently, the 2023 National Survey on Drug Use and Health, conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA), found that 16.6% of people ages 18 to 35 had the condition.

Area physicians have seen an increase in both CUD and cannabis-induced psychosis.

“We don't have clear data on the number of cannabis-induced psychosis cases here in Pittsburgh, but we have a trend towards seeing more people who use cannabis developing psychotic manifestations, particularly adolescents and young people,” Antoine Douaihy, professor of psychiatry and medicine at Pitt and a physician, said in an email statement.

“This may be due to higher potency cannabis that is available recently or cannabis being laced with stimulants such as cocaine, which is also linked with more severe psychotic symptoms. There is also evidence that some individuals may have brain circuitry that could predispose them to cannabis-induced psychotic disorder.”

Advertise with us

Elizabeth Cuevas, division chief for the Center for Inclusion Health at Allegheny Health Network, said that often when patients present with symptoms of psychosis or schizophrenia, disentangling cause and effect is made more challenging by polysubstance use.

“Psychosis is always really hard to tease out because there are so many factors involved,” she said. “When people have psychosis, drug use is something you rule out.”

For the McGill study, Ahrens with a cohort of 61 people between the ages of 18 and 35, many who had sought treatment for early psychosis. The research team partnered with psychologists to document participants’ symptoms of psychosis and tested their saliva for THC concentration.

They then imaged their brains using an MRI technique looking at neuromelanin, a chemical byproduct of dopamine that accumulates in brain cells that make the neurotransmitter and binds to iron, making it partially magnetic and giving it contrast so researchers can view it on scans.

Examining scans — captured during the trial period and at a one-year follow-up — researchers saw that participants with CUD had stronger neuromelanin signals in portions of the substantia nigra, which have been previously linked to psychosis, suggesting a potential link for cannabis-induced psychosis.

Advertise with us

Michelle West, a clinical psychologist who works with patients showing signs of psychosis and teaches in the department of psychiatry at University of Colorado Anschutz Medical Campus said about 70% of patients that come into the clinic with psychosis symptoms report using cannabis. She was not involved in the new study.

For context, in SAMHSA’s 2023 drug survey reported that 21.8% of people in the U.S. over the age of 12, or 62 million people, used cannabis in some form.

Cannabis use and psychosis symptoms have been a common problem for a while, she said.

“The link between cannabis and risk for psychosis for vulnerable people is very well-established,” West added. Those at high risk include people with a family history of schizophrenia, with an unidentified genetic predisposition or those who are already displaying signs of psychosis.

West lauded the study for taking a neurobiological approach and seeking to identify a specific mechanism in this process.

Advertise with us

Focusing on dopamine is only one part of the picture, said West. The dopamine theory of psychosis is well-studied, given that many people with schizophrenia are found to have an excess of dopamine and are treated with medication that lowers their levels.

Additional theories about the mechanisms of psychosis include the role of an excitatory chemical in the brain called glutamate, as well as the neurotransmitter serotonin.

“There are still a lot of unanswered questions about why [cannabis use disorder and psychosis] co-occur,” West said.

While the results were not out of bounds for what researchers expected, Ahrens was surprised by how participants’ dependence on cannabis was perceived.

“It seemed that people with cannabis use disorder didn’t recognize they had a problem,” she said. “There was a lower perception of harm in those individuals, even compared to people in the study without cannabis use disorder.”

Advertise with us

Cannabis use has become so prevalent that physicians “don’t bat an eye,” said Cuevas.

It’s something to consider as cannabis legalization continues to sweep the nation, Pennsylvania included, said Cuevas.

In both of his annual budget proposals, Gov. Josh Shapiro has urged lawmakers to pass legislation for recreational marijuana. (Matt Rourke / Associated Press)

The commonwealth has seen a push-pull regarding cannabis, with the drug legal for recreational use in five out of its six border states. (West Virginia, like Pennsylvania, has medical marijuana.) Governor Josh Shapiro said early in his term that he supports legalization, and in his February budget address encouraged lawmakers to get a bill on his desk to sign.

House Bill 1200, to allow for recreationally legal cannabis, passed May 7 along party lines, 102–101, and then was swiftly voted down in a Senate committee Tuesday. While the concept has seen bipartisan support, Republican policymakers have said the bill causes more harm than good. Dan Laughlin, R-Erie, chair of the Senate Law and Justice Committee, supports legalization and said he’s willing to compromise on aspects of the bill.

Cuevas worries THC content in cannabis will only get stronger, and that side effects from the drug — including psychosis — may increase as a result of legalization.

Advertise with us

But judgement and fearmongering about cannabis are tactics that do not tend to work, West and Ahrens echoed.

In the clinic, West focuses on discussing the potential consequences of cannabis use without giving a certain directive, she said. She may suggest reducing use without cutting it out completely, or switching to a strain that has a lower THC potency.

“There’s a lot of really intense feelings about substances and cannabis, specifically a lot of fear,” she said. “I do think we try to stay in the middle ground.”